GOING CONCERN	3 Months Ended
May. 31, 2015
Going Concern [Abstract]
Going Concern	NOTE 4 - GOING CONCERN The accompanying financial statements have been prepared on a going concern basis which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the financial statements, during the three months ended May 31, 2015 and 2014, respectively, the Company incurred net losses of $91,526 and $13,086 and as of May 31, 2015 had an accumulated deficit of $554,946. The KollagenX Inc. revenue for the three months ended May 31, 2015 was $97,743 as compared to $74,692 for the same period in 2014. If the Company is unable to generate profits and is unable to continue to obtain financing for its working capital requirements, it may have to curtail its business sharply or cease business altogether. These factors raise substantial doubt about the Company's ability to continue as a going concern. The financial statements do not include any adjustment relating to the recoverability and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The Company is taking steps to provide the necessary capital to continue its operations. These steps include, but are not limited to: 1) focus on sales to minimize the need for capital; 2) converting part of the outstanding accounts payable to equity; 3) raising equity financing; 4) continuous focus on reductions in cost where possible.

GOING CONCERN

3 Months Ended

May. 31, 2015

NOTE 4 - GOING CONCERN

The accompanying financial statements have been prepared on a going concern basis which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the financial statements, during the three months ended May 31, 2015 and 2014, respectively, the Company incurred net losses of $91,526 and $13,086 and as of May 31, 2015 had an accumulated deficit of $554,946. The KollagenX Inc. revenue for the three months ended May 31, 2015 was $97,743 as compared to $74,692 for the same period in 2014. If the Company is unable to generate profits and is unable to continue to obtain financing for its working capital requirements, it may have to curtail its business sharply or cease business altogether. These factors raise substantial doubt about the Company's ability to continue as a going concern.

The financial statements do not include any adjustment relating to the recoverability and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

The Company is taking steps to provide the necessary capital to continue its operations. These steps include, but are not limited to: 1) focus on sales to minimize the need for capital; 2) converting part of the outstanding accounts payable to equity; 3) raising equity financing; 4) continuous focus on reductions in cost where possible.

KollagenX Corp. 10-Q